On 8/17/2021 Canaccord Genuity brokerage Lower Price Target for SESN giving a Buy rating from $7.00 to $3.00.
Sesen Bio ( SESN ) flagship drug candidate Vicineum, failed to obtain FDA approval, but they will try a second time to get the regulatory go-ahead for the bladder cancer treatment.
buying long term calls could be a strategy for this one. volatility is likely after they announce the second FDA submission.
Sesen Bio ( SESN ) flagship drug candidate Vicineum, failed to obtain FDA approval, but they will try a second time to get the regulatory go-ahead for the bladder cancer treatment.
buying long term calls could be a strategy for this one. volatility is likely after they announce the second FDA submission.
BUY-SELL indicators: https://tradingindicators.store/ ASK FOR A FREE TRIAL!!!
How to install the indicators: https://www.youtube.com/watch?v=VsJ3V3Uczsk&t=2s&ab_channel=TradingIndicators
My Best Stock Picks: https://www.patreon.com/tradingindicators
How to install the indicators: https://www.youtube.com/watch?v=VsJ3V3Uczsk&t=2s&ab_channel=TradingIndicators
My Best Stock Picks: https://www.patreon.com/tradingindicators